These wildtype GBMs are the dominant subset of grade 4 diffuse astrocytomas and carry a worse prognosis than their IDH mutant counterparts (astrocytoma, IDH mutant, CNS WHO grade 4). Here, IDH2 is linked to astrocytoma (excluding glioblastoma).